Louis Sullivan

Louis Sullivan

Direktor/Vorstandsmitglied bei UNITED THERAPEUTICS CORPORATION

Vermögen: 4 Mio $ am 31.05.2026

92 Jahre
Commercial Services
Consumer Services
Health Technology

Profil

Louis Wade Sullivan is the founder of Medical Education for South African Blacks.
Currently, Dr. Sullivan is Chairman & Chief Executive Officer at The Sullivan Alliance since 2014, Co-Chairman at Henry Schein Cares Foundation, Inc., Independent Director at United Therapeutics Corp.
since 2002, President at Morehouse School of Medicine since 1993, and Trustee at America's Public Television Stations since 2011.
Formerly, Dr. Sullivan was Non-Executive Chairman at ANI Pharmaceuticals, Inc. from 2011 to 2013, Chairman at The National Health Museum, Chairman at Public Broadcasting Atlanta, Chairman-Medical Education at South African Blacks, Inc., Independent Director at Bristol Myers Squibb Co., Director at Cigna Holding Co. from 1993 to 2006, Director at Equifax, Inc., Director at General Motors Corp., Director at Georgia-Pacific LLC, Director at Household International, Inc., Director at 3M Co., Independent Director at Henry Schein, Inc. from 2003 to 2016, Director at Inhibitex LLC, Director at Africare, Inc., Director at Project HOPE-The-People-To-People Health Foundation, Inc., Director at Partnership To End Addiction, Co-Director-Hematology Division at Boston University Medical Center Hospital, Director at The Cigna Group, Independent Director at Emergent BioSolutions, Inc. from 2006 to 2025, Assistant Professor at Seton Hall University in 1965, Member-National Executive Council at Scouting America, Trustee at Little League Baseball, Inc., Secretary at US Department of Health & Human Services from 1989 to 1993, President at Morehouse School of Medicine from 1981 to 1989, and Professor at Boston University School of Medicine in 1975.
Education includes undergraduate degree from Morehouse College in 1954 and doctorate from Boston University School of Medicine in 1958.

Bekannte Unternehmensbeteiligungen

UnternehmenDatumAnzahl der AktienBewertungDatum der Bewertung
10.04.2026 3’790 ( 0.01% ) 2 Mio $ 31.05.2026
30.04.2025 139’098 ( 0.27% ) 1 Mio $ 31.05.2026
16.03.2026 2’777 ( 25.56% ) 218 022 $ 31.05.2026

Aktive Positionen von Louis Sullivan

UnternehmenPositionBeginn
UNITED THERAPEUTICS CORPORATION Direktor/Vorstandsmitglied 01.01.2002
Präsident 01.01.1993
Vorsitzender -
The Sullivan Alliance
Vorstandsvorsitzender -
Direktor/Vorstandsmitglied 10.01.2011

Ehemalige bekannte Positionen von Louis Sullivan

UnternehmenPositionEnde
EMERGENT BIOSOLUTIONS INC. Direktor/Vorstandsmitglied 14.11.2025
HENRY SCHEIN, INC. Direktor/Vorstandsmitglied 01.06.2016
ANI PHARMACEUTICALS, INC. Vorsitzender 19.06.2013
Direktor/Vorstandsmitglied 19.09.2007
░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
Sehen Sie sich die Erfahrung von Louis Sullivan im Detail an

Ausbildung von Louis Sullivan

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Beziehungen

63

Beziehungen ersten Grades

30

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Unternehmensverbindungen

Private Unternehmen30

Health Technology

Finance

Commercial Services

Consumer Durables

Non-Energy Minerals

Finance

Producer Manufacturing

Distribution Services

Health Technology

Health Technology

Health Technology

Consumer Services

Consumer Services

Commercial Services

Health Technology

Commercial Services

Consumer Services

Government

Health Services

Consumer Services

Commercial Services

The National Health Museum

Commercial Services

Commercial Services

Boston University Medical Center Hospital

Consumer Services

Consumer Services

The Sullivan Alliance

Health Services

  1. Börse
  2. Insiders
  3. Louis Sullivan